Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Results from a Phase 1/2, Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma Duvic, M., Horwitz, S. M., Kim, Y. H., Zinzani, P., Bhat, G., Sharma, P., Yancik, S. AMER SOC HEMATOLOGY. 2015
View details for Web of Science ID 000368020102189